KBKathleen Byrnes

Kathleen Byrnes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kathleen Byrnes has a total of 116 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Anal canal neoplasms in the modern era: integrating HPV biology, LAST terminology, and evolving molecular classification

    by Kathleen Byrnes, Lysandra Voltaggio

    Anal canal neoplasia comprises a heterogeneous and evolving group of precursor lesions and invasive malignancies whose classification increasingly depends on integrating morphology, human papillomavirus association, immunophenotype, and molecular alterations. This review summarizes current concepts in the pathology of anal canal neoplasms, with emphasis on practical application of Lower Anogenital Squamous Terminology, distinction between low-grade and high-grade squamous intraepithelial lesions, and the role of ancillary testing in diagnostically challenging cases. We discuss the expanding spectrum of invasive neoplasms, including human papillomavirus-driven and human papillomavirus-independent squamous cell carcinoma, anorectal neuroendocrine carcinoma, and anal adenocarcinoma, highlighting recently described subtypes and their clinicopathologic significance. Attention is given to emerging molecular correlates, including alterations in TP53, CYLD, and other oncogenic pathways, which may refine classification and prognostic stratification. The review also addresses unresolved issues, including precursor lesions for human papillomavirus-independent disease, evolving terminology for glandular and mixed lesions, and controversy regarding staging of anal adenocarcinoma. By combining contemporary terminology with morphologic, immunohistochemical, and molecular findings, this review provides a practical framework for pathologists navigating an uncommon but increasingly complex diagnostic area.

  • Open Access

    Unique Features and Pitfalls in Grading and Diagnosis of Graft-Versus-Host Disease (GVHD) in Duodenum

    by Jiannan Li, Manli Shen, Kathleen Byrnes

    Objectives: Graft-versus-host disease (GVHD) is a severe complication of stem cell transplantation, affecting multiple organs, including the GI tract. Current guidelines use identical grading criteria regardless of location or treatment status. This study describes the histologic features of duodenal GVHD with and without treatment. Methods: A total of 176 cases were reviewed for apoptosis, crypt abscesses, crypt dropout, reactive changes, and villous blunting. Results: Apoptosis ranged from mild (61.4%), moderate (21.0%), to severe (17.6%), correlating with crypt dropout (r=0.83, p<0.01), reactive changes (r=0.66, p<0.01), crypt abscesses (r=0.56, p<0.01), and villous blunting (r=0.77, p<0.01). Apoptosis severity also correlated with endoscopic findings (r=0.38, p<0.01) and adverse clinical outcomes (r=0.26, p<0.01), but not symptoms (r=0.03, p=0.7). Histologic findings were patchy in 22.7% of cases but were not detected endoscopically (r=0.25, p=0.12). Crypt dropout, crypt disruption, and villous blunting correlated with clinical outcomes and GVHD grade (p<0.01), whereas crypt abscesses did not (p=0.054, p=0.47). GVHD severity predicted poorer clinical response (p=0.01), regardless of prior treatment, which did not alter histologic findings. HLA match status did not correlate with any histologic features or severity of disease. Conclusions: Our study shows that adequate sampling with multiple biopsies is crucial due to histologic heterogeneity, which may lead to misclassification. Crypt abscesses are unreliable for grading, while apoptosis, crypt dropout, and villous blunting are key diagnostic and grading features, which is not affected by HLA match status.

  • Open Access

    HCC Metastasis to the Sigmoid Colon and Rectum

    by Kamal Kolluri, Kathleen Byrnes, Lindsay Meurer, Jason J. Pan

  • Open Access

    Development of Colonic Polyposis in a Woman With Chronic Myeloid Leukemia Treated With Dasatinib

    by Guido Pelaez, Behram Suha Yildiz, Mert Candan, Mohammad Ismail, Francesca Vacca, Marianna B. Ruzinova, Samuel Ballentine, Kathleen Byrnes, Armin Ghobadi

    Introduction: Chronic myeloid leukemia (CML) is a hematopoietic malignancy driven by constitutive tyrosine kinase activity. Dasatinib, a second‐generation (2G) tyrosine kinase inhibitor (TKI), is a preferred treatment due to its superior, durable, and rapid response rates. While dasatinib has known gastrointestinal (GI) side effects, colonic polyposis is a rare complication, not well described in the literature. Case Presentation: Upon routine colonoscopy, a 66‐year‐old woman with chronic‐phase CML was incidentally discovered to have asymptomatic colonic polyposis after 11 months of dasatinib therapy. Histopathology revealed reactive inflammatory changes without evidence of dysplasia or neoplasia. The polyposis resolved completely after cessation of dasatinib. Conclusion: The mechanism behind dasatinib‐induced polyposis is unclear. We hypothesize a role of dasatinib’s differential inhibition of multiple kinase pathways, regulatory T cells, and STAT5 signaling in the intestinal epithelium, causing an unregulated inflammatory state. This case underscores the need for awareness of this rare adverse effect and further research into its pathogenesis.


  • Open Access

    Induction of TFEB promotes Kupffer cell survival and reduces lipid accumulation in MASLD

    by Mandy M. Chan, Sabine Daemen, Wandy Beatty, Kathleen Byrnes, Kevin Cho, Daniel Ferguson, Natalie Feldstein, Christopher Park, Zhen Guo, Arick C. Park, et al.

    Background: Kupffer cells (KCs) are the tissue-resident macrophages of the liver, where they serve a critical role in maintaining liver tissue homeostasis and act as a filter for circulation. The composition of hepatic macrophages changes during metabolic dysfunction–associated liver disease (MASLD), with the loss of resident KCs being a hallmark of disease progression. The mechanism(s) and consequences of KC death in metabolic liver disease have yet to be defined. Transcription factor EB (TFEB) is a master regulator of lysosome function and lipid metabolism, which has been shown to protect macrophages from lipid stress in atherosclerosis. We hypothesized that TFEB would improve KC fitness in MASLD. Methods: To investigate the potential beneficial effect of TFEB induction in KCs, we created a transgenic mouse in which TFEB was overexpressed specifically in KCs and evaluated its impact on disease pathogenesis in high-fat, high-sucrose (HFHS) and choline-deficient diet models of MASLD. Results: We found that TFEB induction protected KCs from cell death in both models of MASLD. KC preservation through TFEB induction reduced liver steatosis with HFHS diet via mechanisms that were dependent on macrophage lysosomal lipolysis and mitochondrial fatty acid oxidation. Fibrosis was unchanged in choline-deficient diet studies. TFEB protected KCs from cell death by diminishing oxidative stress and reducing ferroptosis through a mechanism that involved enhanced NADPH levels. Conclusions: TFEB induction promotes KC fitness upon lipid stress during MASLD. Preservation of lipid-adapted KCs demonstrates beneficial effects against liver steatosis and protects portal filtration during MASLD.


  • Heterogeneity of pancreatic neoplasms arising in pancreatic heterotopia: a single institution review

    by Kathleen Byrnes, Liang Kang, Ryan Sappenfield, Xiuli Liu

    Pancreatic heterotopia (PH) is a well-characterized entity that can arise in the gastrointestinal tract. Many pancreatic disease processes, ranging from inflammatory to neoplastic, can also be seen in PH. Neoplastic transformation in PH remains exceedingly rare. A retrospective review of PH cases (1990 to 2020) excised at our institution was performed. Cases were selected based on prior criteria for identifying neoplastic transformation in PH. Clinical information was obtained through the electronic medical record. A total of 163 gastrointestinal tract PH cases were identified. Of these, seven had a neoplastic process in the heterotopic pancreas: two with well-differentiated neuroendocrine tumors, three with pancreatic intraepithelial neoplasia, and one each developed ductal adenocarcinoma or neuroendocrine microadenoma. The majority were men (71.4%) with a median age of 64 years. Seven patients had clinical symptoms including weight loss, abdominal pain, and small bowel obstruction. Five cases arose in the small intestine and two cases arose in the stomach. Lesions involved the submucosa (42.8%), serosa (28.6%), and muscularis propria (28.6%). In all cases, the PH was composed of acini, ducts, and islet cells. The mean follow-up time was 55 months (range: 3–159 months). One patient had regional lymph node metastasis and died with disease from surgical complications. No cases of distant metastasis were identified. Neoplasia in PH is a rare phenomenon that can occur, including malignant entities such as ductal adenocarcinoma, but also other tumor types. Recognition of this entity remains important for pathologists to avoid diagnostic confusion and provide accurate tumor staging.

  • Open Access

    Molecular imaging of macrophage composition and dynamics in MASLD

    by Bin Q. Yang, Mandy M. Chan, Gyu Seong Heo, Lanlan Lou, Hannah Luehmann, Christopher Park, Alexandria Li, Divangana Lahad, Deborah Sultan, Peter Voller, et al.


  • Utility of special AT-rich sequence-binding protein 2 (SATB2) immunohistochemistry as a marker for secondary perianal paget disease

    by Krithika Shenoy, Kathleen Byrnes

    A panel-based approach using immunohistochemistry (IHC) is currently used for subtyping perianal Paget disease (PPD) in the absence of a synchronous neoplasm. Special AT-rich Sequence Binding Protein 2 (SATB2) has been established as a sensitive and specific marker for lower gastrointestinal tract carcinomas. We evaluated its performance as a marker of secondary PPD. A panel of IHCs including CK7, CK20, GCDFP-15, CDX2, and SATB2 were performed on fifteen cases of PPD (identified between 1991–2001) and seven cases of primary vulvar Paget disease with perianal involvement. Eight cases (53%) were classified as secondary PPD based on the presence of a synchronous (n = 7) or a metachronous neoplasm (n = 1). There was no differential staining for CK7 (positive in 7/7 primary vs. 7/8 secondary PPD; P = 1.00) and CK20 (positive in 4/7 primary vs. 8/8 secondary PPD; P = .08). GCDFP-15 was positive in 5/7 cases of primary PPD while negative in all cases of secondary PPD (P = .01). CDX2 was positive in all cases of secondary PPD (P = .001) while SATB2 was positive in 7/8 cases of secondary PPD (P = .01). Both CDX2 and SATB2 were positive in 1/7 cases of primary PPD. The addition of an IHC panel in conjunction with clinical/imaging findings can help definitively classify PPD as either primary or secondary in most cases. We show that SATB2 has comparable performance to CDX2 and can be a helpful additional tool.


  • Open Access

    Primary Non-Function of Hepatic Allograft With Preexisting Microvesicular Steatosis/Foamy Degeneration and Mild Large-Droplet Macrovesicular Steatosis

    by Melissa E. Limia, Xiu Li Liu, Jennifer Yu, Kathleen Byrnes

    Primary Non-Function of Hepatic Allograft With Preexisting Microvesicular Steatosis/Foamy Degeneration and Mild Large-Droplet Macrovesicular Steatosis


  • The Brief Case: Granulomatous hepatitis in an immunocompromised patient

    by Pooja Khonde, Kathleen Byrnes

    A 32-year-old man with HIV presented to the emergency department with fever, malaise, and a significant weight loss of 15 pounds in 1 month. The patient had a history of non-compliance and a drug-resistant HIV genotype. The patient also had a history of disseminated cytomegalovirus (CMV), recurrent rectal gonorrhea and chlamydia, syphilis, and a urogenital herpse simplex virus (HSV) infection. The patient had no known exposure to cats or lymphadenopathy.